Changes in FMD (% ± SD) in patient subgroup with decreased body weight during observation period. by Haruka Tamura (153793)

Cell proliferation was significantly decreased in full-length HPV16 E1 (pEGFP-E1) transfected cells. by Fern Baedyananda (11888703)

Increased and decreased proteins. by Diego Iacono (10785756)

Proportions of intervals where cytokines change varies between cytokines. by Jordan K. Abbott (8934239)

Subjects:

IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

Subjects:

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

STAT6 siRNA sequences 1 and 4 significantly block STAT6 expression. by Carmen Salguero-Aranda (6690044)

Ranked OD net percent decrease. by Jimy Pinto (4376539)

EmSFRP expression is decreased in sponges treated with dsRNA to EmPaxB. by Chelsea Hall (6392540)

AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased. by Margaret Coates (6058580)

“…<p>(A) Volcano plot showing increased or decreased genes in HS. Graph shows log FC in gene expression of HS lesional skin over HS non-lesional skin samples plotted against negative log p-value of the difference in gene expression. …”

Analysis of Significantly Different ARGs and Resistance Mechanisms. by Xu Jia (187142)

Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss. by Thomas R. Shearer (9761486)

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Afatinib decreases MAPK and AKT activation after MET knockdown. by Karolin Ebert (7434713)

Decreased cytokine production by moDCs upon TLR stimulation when preincubated with NSAIDs. by Tonke K. Raaijmakers (13955749)

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

“…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)